Dissociating the enhancing and inhibitory effects of pertussis toxin on autoimmune disease

Journal of Immunology

Volumn 171, Issue 5, 2003, Pages 2314-2319

  Su, Shao Bo ^a   Silver, Phyllis B ^a   Wang, Peng ^a   Chan, Chi Chao ^a   Caspi, Rachel R ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MESSENGER RNA; PERTUSSIS TOXIN; POLYMYXIN B; PROTEINASE K; RETINA ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SPLEEN CELL; TH1 CELL; UVEITIS;

EID: 0042430414     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.5.2314     Document Type: Article

References (32)

1. Merritt, E. A., and W. G. Hol. 1995. AB5 toxins. Curr. Opin. Struct. Biol. 5:165.
2. Kaslow, H. R., and D. L. Burns. 1992. Pertussis toxin and target eukaryotic cells: binding, entry, and activation. FASEB J. 6:2684.
3. Wong, W. S., and P. M. Rosoff. 1996. Pharmacology of pertussis toxin B-oligomer. Can. J. Physiol. Pharmacol. 74:559.
4. Saukkonen, K., W. N. Burnette, V. L. Mar, H. R. Masure, and E. I. Tuomanen 1992. Pertussis toxin has eukaryotic-like carbohydrate recognition domains. Proc. Natl. Acad. Sci. USA 89:118.
5. Van't Wont, J., W. N. Burnette, V. L. Mar, E. Rozdzinski, S. D. Wright, and E. I. Tuomanen. 1992. Role of carbohydrate recognition domains of pertussis toxin in adherence of Bordetella pertussis to human macrophages. Infect. Immun. 60:3303.
6. Raine, C. S. 1984. Biology of disease: analysis of autoimmune demyelination its impact upon multiple sclerosis. Lab. Invest. 50:608.
7. Tuohy, V. K. 1994. Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review. Neurochem. Res. 19:935.
8. Kerlero de Rosbo, N., I. Mendel, and A. Ben-Nun. 1995. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Eur. J. Immunol. 25:985.
9. Mendel, I., N. Kerlero de Rosbo, and A. Ben-Nun. 1995. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor Vβ expression of encephalitogenic T cells. Eur. J. Immunol. 25:1951.
10. Caspi, R. R., F. G. Roberge, C. C. Chan, B. Wiggert, G. J. Chader, L. A. Rozenszajn, Z. Lando, and R. B. Nussenblatt. 1988. A new model of autoimmune disease: experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J. Immunol. 140:1490.
11. Hart, M. N., D. S. Linthicum, M. M. Waldschmidt, S. K. Tassell, R. L. Schelper, and R. A. Robinson. 1987. Experimental autoimmune inflammatory myopathy. J. Neuropathol. Exp. Neurol. 46:511.
12. Caspi, R. 1997. Experimental autoimmune uveoretinitis (EAU) - mouse and rat. In Current Protocols in Immunology, Vol. January. A. Kruisbeck, D. Margulies, E. Shevach, and W. Strober, eds. John Wiley & Sons, New York, p. Unit 15.6.
13. Hofstetter, H. H., C. L. Shive, and T. G. Forsthuber. 2002. Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells. J. Immunol. 169:117.
14. He, J., S. Gurunathan, A. Iwasaki, B. Ash-Shaheed, and B. L. Kelsall. 2000. Primary role for Gi protein signaling in the regulation of interleukin 12 production and the induction of T helper cell type 1 responses. J. Exp. Med. 191:1605.
15. Su, S. B., P. B. Silver, M. Zhang, C. C. Chan, and R. R. Caspi. 2001. Pertussis toxin inhibits induction of tissue-specific autoimmune disease by disrupting G protein-coupled signals. J. Immunol. 167:250.
16. Agarwal, R. K., S. H. Sun, S. B. Su, C. C. Chan, and R. R. Caspi. 2002. Pertussis toxin alters the innate and the adaptive immune response in a pertussis-dependent model of autoimmunity. J Neuroimmunol. 129:133.
17. Pepperberg, D. R., T. L. Okajima, H. Ripps, G. J. Chader, and B. Wiggert. 1991. Functional properties of interphotoreceptor retinoid-binding protein. Photochem. Photobiol. 54:1057.
18. Falk, W., R. H. Goodwin, Jr., and E. J. Leonard. 1980. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J. Immunol. Methods 33:239.
19. + leukocytes by HIV-1 envelope protein gp120. Chem. Immunol. 72:141.
20. Tarrant, T. K., P. B. Silver, J. L. Wahlsten, L. V. Rizzo, C. C. Chan, B. Wiggert, and R. R. Caspi. 1999. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon γ, nitric oxide, and apoptosis. J. Exp. Med. 189:219.
21. Xu, H., L. V. Rizzo, P. B. Silver, and R. R. Caspi. 1997. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Cell. Immunol. 178:69.
22. Caspi, R. R., P. B. Silver, C. C. Chan, B. Sun, R. K. Agarwal, J. Wells, S. Oddo, Y. Fujino, F. Najafian, and R. L. Wilder. 1996. Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response. J. Immunol. 157:2668.
23. Silver, P. B., C. C. Chan, B. Wiggert, and R. R. Caspi. 1999. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment. Invest. Ophthalmol. Visual Sci. 40:2898.
24. Trinchieri, G. 1998. Proinflammatory and immunoregulatory functions of interleukin-12. Int. Rev. Immunol. 16:365.
25. Tarrant, T. K., P. B. Silver, C. C. Chan, B. Wiggert, and R. R. Caspi. 1998. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis. J. Immunol. 161:122.
26. Mathew, A., B. D. Medoff, A. D. Carafone, and A. D. Luster. 2002. Cutting edge: Th2 cell trafficking into the allergic lung is dependent on chemoattractant receptor signaling. J. Immunol. 169:651.
27. Alfano, M., G. Vallanti, P. Biswas, C. Bovolenta, E. Vicenzi, B. Mantelli, T. Pushkarsky, R. Rappuoli, A. Lazzarin, M. Bukrinsky, and G. Poli. 2001. The binding subunit of pertussis toxin inhibits HIV replication in human macrophages and virus expression in chronically infected promonocytic U1 cells. J. Immunol. 166:1863.
28. Alfano, M., T. Pushkarsky, G. Poli, and M. Bukrinsky. 2000. The B-oligomer of pertussis toxin inhibits human immunodeficiency virus type 1 replication at multiple stages. J. Virol. 74:8767.
29. Tamura, M., K. Nogimori, M. Yajima, K. Ase, and M. Ui. 1983. A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells. J. Biol. Chem. 258:6756.
30. Ryan, M., L. McCarthy, R. Rappuoli, B. P. Mahon, and K. H. Mills. 1998. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28. Int. Immunol. 10:651.
31. Brenner, T., and O. Abramsky. 1993. Natural and experimental transfer of antipertussis antibodies confers resistance to experimental autoimmune encephalomyelitis. J. Neurol. Sci. 114:13.
32. Ben-Nun, A., I. Mendel, and N. Kerlero de Rosbo. 1997. Immunomodulation of murine experimental autoimmune encephalomyelitis by pertussis toxin: the protective activity, but not the disease-enhancing activity, can be attributed to the nontoxic B-oligomer. Proc. Assoc. Am. Physicians 109:120.